• The LRRK2 mutation carriers were more likely to be referred for DBS surgery because of severe dyskinesia • Significant reduction in LEDD after surgery in both mutation carriers and non-mutation carriers • Greater reduction in LEDD in those underwent STN DBS as compared with those underwent GPi DBS. This evidence concerns the gene LRRK2 and drug-induced dyskinesia.